Heidelberg Pharma AG
DUS:HPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Heidelberg Pharma AG
DUS:HPHA
|
DE |
|
B
|
Blackstone Mortgage Trust Inc
SWB:079A
|
US |
|
C
|
Colliers International Group Inc
F:FSV
|
CA |
|
J
|
JD.com Inc
SWB:013A
|
CN |
|
KT&G Corp
KRX:033780
|
KR |
|
loanDepot Inc
F:LDD
|
US |
|
D
|
Deutsche Telekom AG
XHAM:DTE
|
DE |
|
Finwise Bancorp
NASDAQ:FINW
|
US |
|
Hyatt Hotels Corp
NYSE:H
|
US |
|
P
|
PPC Ltd
JSE:PPC
|
ZA |
|
A
|
Anheuser-Busch Inbev SA
F:ITKA
|
BE |
|
Synopsys Inc
NASDAQ:SNPS
|
US |
|
T
|
Tencent Holdings Ltd
XHAN:NNND
|
CN |
|
N
|
NiSource Inc
F:NOU
|
US |
|
B
|
Banco Santander SA
XHAN:BSD2
|
ES |
|
D
|
Daiwa House Industry Co Ltd
XMUN:DWH
|
JP |
|
Snam SpA
OTC:SNMRF
|
IT |
|
Ventas Inc
NYSE:VTR
|
US |
Bankruptcy Probability
Heidelberg Pharma AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Heidelberg Pharma AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Heidelberg Pharma AG
XETRA:HPHA
|
118.8m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
463.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
58.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
49.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Heidelberg Pharma AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Heidelberg Pharma AG has total debt of 52.9m EUR. This includes both short-term (0 EUR) and long-term (52.9m EUR) debt.
You can find a full breakdown on its Balance Sheet.